Home
About
Board of Directors
Management
Scientific Advisory Board
Consultant Team
Technology
Tocotrienols
Nutraceuticals
Clinical Development Strategy
Why NAFLD/NASH
Why Pancreatic Cancer
The AZT Therapeutics Program
Investors
Corporate Governance
Corporate Directory
Announcements
Events
Contact
Announcements
Azure Health Technology Limited successfully completes Capital Raise - 03 June 2020
Azure Health Technology Limited acquires Invictus BioPharma Limited - 11 June 2020
Azure Health Technology Limited commences preparations for NAFLD/NASH Phase II clinical study - 15 June 2020
Azure Health Technology Limited commences preparations for pancreatic cancer Phase II clinical study - 22 June 2020
Azure Health Technology Limited appoints Non-Executive Director - 02 July 2020
Azure Health Technology Completes study protocol for NAFLD/NASH Phase II
clinical
study - 31 July 2020
Azure Health Technology Limited commences first manufacturing run in the US for nutraceutical products - 24 August 2020
Azure Health Technology completes study protocol for Pancreatic Cancer Phase II clinical study - 21 September 2020
Canadian Patent Office issues Notice of Allowance for Canadian Patent Application -
24 September 2020
TOP
